HomeAI · summaries
Storia in 6 fonti
'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% storm
US Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly after August 1, 2026, impacting imports. The issue was not raised during his discussions with India's External Affairs Minister S Jaishankar. However, the matter might have been discussed with other US administration members. Both nations also underscored concluding an interim bilateral trade arrangement.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
hindustantimes.com
0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines
In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. | India News
- ·
newsbytesapp.com
Trump threatens tariff on generic medicines: Should India be worried?
US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.
